Cost burden and net monetary benefit loss of neonatal hypoglycaemia.

Matthew J GlasgowRichard EdlinJane Elizabeth Harding
Published in: BMC health services research (2021)
Even under the most conservative of estimates, neonatal hypoglycaemia contributes a significant financial burden to the health system both during childhood and over a lifetime. The combination of direct costs and loss of quality of life due to neonatal hypoglycaemia means that this condition warrants further research to focus on prevention and effective treatment.